TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11306777

Group type: EXPERIMENTAL
Intervention: Aphasia and neglect as assessed by the NIHSS in acute stroke patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcortical aphasia or neglect
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIHSS measures of aphasia and neglect
Number of subjects: 0
Study: 9340953

Group type: EXPERIMENTAL
Intervention: Parenteral gold and methotrexate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Baseline (T0)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: T1 (after 36 months)
Number of subjects: 24
Study: 7880658

Group type: EXPERIMENTAL
Intervention: Crystalloid (lactated Ringer's) 15 ml kg‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Colloid (hydroxyethyl starch) 7.5 ml kg‐1
Number of subjects: 20
Study: 3284218

Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem (0.3 mg/kg body weight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31891544

Group type: EXPERIMENTAL
Intervention: Prefilled disposable tray containing potassium nitrate and fluoride
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional tray containing potassium nitrate and fluoride
Number of subjects: 78
Study: 29105107

Group type: EXPERIMENTAL
Intervention: SPF 70 lotion sunscreen applied at a dosage of 2 mg cm‐2 on half of the face
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SPF 70 spray sunscreen applied at a dosage of 2 mg cm‐2 on one of the forearms
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated control sites (no sunscreen)
Number of subjects: 24
Study: 27522535

Group type: EXPERIMENTAL
Intervention: Active cannabis (3.56‐5.60% THC)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Inactive cannabis (0.00% THC)
Number of subjects: 42
Study: 26720884

Group type: EXPERIMENTAL
Intervention: Blue light-emitting toothbrushes (B-LETBs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard toothbrushes (Control)
Number of subjects: 0
Study: 23559082

Group type: COMPARATOR
Intervention: 400 IU/d vitamin D3
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 2000 IU/d vitamin D3
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: 4000 IU/d vitamin D3
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Safety measurements
Number of subjects: 192
Study: 20599042

Group type: EXPERIMENTAL
Intervention: Idebenone (5, 15, and 45 mg/kg, administered orally 3 times a day for 6 months)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (matching placebo for 6 months)
Number of subjects: 48
Study: 18349182

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA) and Laryngeal Tube (LT)
Number of subjects: 40
Study: 17142216

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 112

Group type: COMPARATOR
Intervention: Bedtime insulin
Number of subjects: 112
Study: 12685385

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg twice a day for 7 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg in a single morning dose for 7 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Omeprazole 20 mg twice a day for 7 days and further 3 weeks 20 mg twice a day
Number of subjects: 80
Study: 11153337

Group type: EXPERIMENTAL
Intervention: Ultrasound assessment of bladder volume
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard catheterization
Number of subjects: 153
Study: 8957368

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic talc insufflation under general anesthesia (n = 28)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Talc slurry by the bedside (n = 29)
Number of subjects: 57
Study: 1583760

Group type: EXPERIMENTAL
Intervention: External pneumatic compression (EPC)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Warfarin and EPC
Number of subjects: 232
Study: 3888393

Group type: EXPERIMENTAL
Intervention: Doxepin hydrochloride (50 mg at bedtime for the first week, then 75 mg or 100 mg as needed for the remainder of the six-week trial)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31521551

Group type: EXPERIMENTAL
Intervention: Cryotherapy (packs of crushed ice applied to the knee with mild compression)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham intervention (packs filled with sand)
Number of subjects: 60
Study: 29507952

Group type: EXPERIMENTAL
Intervention: 5-component health care professional HPV vaccine communication intervention
Number of subjects: 43132

Group type: COMPARATOR
Intervention: Control practices
Number of subjects: 43132
Study: 27154767

Group type: EXPERIMENTAL
Intervention: Home-based parenting program (5-month program followed by two 1-month boosters)
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Home-based parenting program
Number of subjects: 1076
Study: 25452854

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention group (ILG)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Usual care group (UCG)
Number of subjects: 294
Study: 22364690

Group type: EXPERIMENTAL
Intervention: Torsemide (1/10 of the daily furosemide dose divided into twice daily dosing)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Furosemide (mean dose 5.13 mg/kg/day)
Number of subjects: 7
Study: 20966667

Group type: EXPERIMENTAL
Intervention: Single-shot femoral nerve block (SSFNB) with concurrent PCA opioids
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Single-shot femoral nerve block (SSFNB) plus sciatic nerve block
Number of subjects: 1016

Group type: COMPARATOR
Intervention: Single-shot femoral nerve block (SSFNB) plus continuous FNB
Number of subjects: 1016
Study: 17683554

Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) assessment in the weeks near death
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) assessment in the prospective analysis
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) assessment in the retrospective analysis
Number of subjects: 115
Study: 12629471

Group type: EXPERIMENTAL
Intervention: Exercise (n=7)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (n=7)
Number of subjects: 14
Study: 11206210

Group type: EXPERIMENTAL
Intervention: few-fixed condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: many-fixed condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: critical items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: list items
Number of subjects: 0
Study: 9377612

Group type: EXPERIMENTAL
Intervention: Zafirlukast (20 mg twice daily)
Number of subjects: 762

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 762
Study: 1588374

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine (HIDAC) 3 g/m2 ara-C infused over 3 hours at 12-hour intervals on days 1, 3, and 5
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine (HIDAC)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Risk model parameters: creatinine greater than or equal to 1.2 mg/dL, age greater than or equal to 40 years, and alkaline phosphatase (AP) greater than or equal to 3 x normal
Number of subjects: 176
Study: 31476786

Group type: EXPERIMENTAL
Intervention: Antenatal administration of betamethasone
Number of subjects: 115
Study: 31510777

Group type: EXPERIMENTAL
Intervention: Carvedilol therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: No carvedilol therapy (control)
Number of subjects: 12
Study: 28353650

Group type: EXPERIMENTAL
Intervention: Text messaging intervention providing strategies for increasing physical activity
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no text messaging intervention)
Number of subjects: 82
Study: 26525720

Group type: EXPERIMENTAL
Intervention: Abnormal cells (arm A)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Pre‐invasive breast cancer cells (arm B)
Number of subjects: 269
Study: 23966615

Group type: EXPERIMENTAL
Intervention: Doppler measurements in severe growth restriction (umbilical artery pulsatility index, MCA pulsatility index, ductus venosus pulsatility index)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Umbilical artery pulsatility index in normally grown fetuses
Number of subjects: 51
Study: 21435907

Group type: EXPERIMENTAL
Intervention: Locking plate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 60
Study: 19746764

Group type: EXPERIMENTAL
Intervention: Moisturizer applied to the right side of the face
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Azelaic acid (AzA) gel 15% applied twice daily
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Facial cleanser used before AzA application
Number of subjects: 102

Group type: COMPARATOR
Intervention: No moisturizer applied to the left side of the face
Number of subjects: 102
Study: 17210892

Group type: EXPERIMENTAL
Intervention: Interictal diffusion-weighted imaging
Number of subjects: 22
Study: 15491065

Group type: EXPERIMENTAL
Intervention: Tamoxifen (10 or 20 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 10762562

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 1178

Group type: COMPARATOR
Intervention: Rifabutin
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Combination therapy (Clarithromycin + Rifabutin)
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Clarithromycin and Combination therapy
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Survival
Number of subjects: 1178
Study: 8732472

Group type: EXPERIMENTAL
Intervention: Menorest 50
Number of subjects: 419

Group type: COMPARATOR
Intervention: Premarin 0.625 mg/day
Number of subjects: 419

Group type: COMPARATOR
Intervention: Estraderm TTS 50
Number of subjects: 419
Study: 1348475

Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal peptide (VIP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 10
Study: 3901675

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 30887671

Group type: EXPERIMENTAL
Intervention: Bathing at 48 hours after birth
Number of subjects: 73

Group type: COMPARATOR
Intervention: Bathing at 24 hours after birth
Number of subjects: 73
Study: 29164798

Group type: EXPERIMENTAL
Intervention: Reduction in CSF Aβ levels and evident tau pathology
Number of subjects: 88

Group type: COMPARATOR
Intervention: Normal levels of tau
Number of subjects: 88
Study: 27197662

Group type: EXPERIMENTAL
Intervention: FEX 60 mg with 150 mL of AJ
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FEX 60 mg with 300 mL of AJ
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FEX 60 mg with 600 mL of AJ
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 10
Study: 25511058

Group type: EXPERIMENTAL
Intervention: Bovine derived hydroxyapatite (BHA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Synthetic hydroxyapatite (SHA)
Number of subjects: 24
Study: 23359361

Group type: EXPERIMENTAL
Intervention: D-xylose preload with sitagliptin (SX)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: D-xylose preload without sitagliptin (PX)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sucralose control (C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: D-xylose preload (X)
Number of subjects: 12
Study: 20802289

Group type: EXPERIMENTAL
Intervention: High magnitude (HM; 50 Hz and 2.51 mmp‐p; 98.55 mxs‐2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low magnitude (LM; 30 Hz and 1.15 mmp‐p; 20.44 m.s‐2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (without vibration stimulus)
Number of subjects: 20
Study: 18206190

Group type: EXPERIMENTAL
Intervention: Encapsulated L-phenylalanine (Phe)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dextrose (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Encapsulated L-phenylalanine (Phe) in the follicular phase for women in the lower 50th percentile of rigid restraint
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Encapsulated L-phenylalanine (Phe) in the luteal phase for women in the higher 50th percentile of rigid restraint
Number of subjects: 20
Study: 16427245

Group type: EXPERIMENTAL
Intervention: In-person counseling
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 340
Study: 12815350

Group type: EXPERIMENTAL
Intervention: C&B Metabond (adhesive resin cement)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Panavia (adhesive resin cement)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fleck's (zinc phosphate cement)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ketac-Cem (conventional glass ionomer cement)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 6-degree taper
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 12-degree taper
Number of subjects: 120
Study: 11078787

Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination (MMSE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardized Mini-Mental State Examination
Number of subjects: 0
Study: 8866639

Group type: EXPERIMENTAL
Intervention: Intracavernous injection of moxisylyte at 10 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intracavernous injection of moxisylyte at 20 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intracavernous injection of moxisylyte at 30 mg
Number of subjects: 18
Study: 1630668

Group type: EXPERIMENTAL
Intervention: Doxofylline (400 mg b.i.d.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Aminophylline (480 mg b.i.d.)
Number of subjects: 14
Study: 30049724

Group type: EXPERIMENTAL
Intervention: Active (<30 mm Hg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate (<gestational age mm Hg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Permissive (<19 mm Hg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (after threshold breached)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cranial ultrasound findings
Number of subjects: 60
Study: 28233684

Group type: EXPERIMENTAL
Intervention: Clensia 2L
Number of subjects: 422

Group type: COMPARATOR
Intervention: PEG 4L
Number of subjects: 422
Study: 24929659

Group type: EXPERIMENTAL
Intervention: Mobile-bearing (MB) design
Number of subjects: 99

Group type: COMPARATOR
Intervention: Fixed-bearing (FB) design
Number of subjects: 99
Study: 23943731

Group type: EXPERIMENTAL
Intervention: Airway integrated Nasopore
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nasopore without airway integration
Number of subjects: 80
Study: 21682545

Group type: EXPERIMENTAL
Intervention: Auditory-visual mode
Number of subjects: 20

Group type: COMPARATOR
Intervention: Auditory-only mode
Number of subjects: 20
Study: 20523282

Group type: EXPERIMENTAL
Intervention: Percutaneous thrombolysis
Number of subjects: 3

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 3
Study: 16957645

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery (fluoroscopic navigation technique)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional operative technique (fluoroscopy)
Number of subjects: 20
Study: 15737519

Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telithromycin 800 mg for 5 days
Number of subjects: 0
Study: 12218421

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance (MR) perfusion imaging
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: H2(15)O Positron Emission Tomography (PET)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance (MR) and H2(15)O PET agreement in white matter
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance (MR) and H2(15)O PET agreement in gray matter
Number of subjects: 20
Study: 9469269

Group type: EXPERIMENTAL
Intervention: Azithromycin, 1 g oral slurry in a single dose
Number of subjects: 106

Group type: COMPARATOR
Intervention: Erythromycin, 500 mg every 6 hours for 7 days
Number of subjects: 106
Study: 7874894

Group type: EXPERIMENTAL
Intervention: Doxacurium
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pancuronium
Number of subjects: 40
Study: 2243372

Group type: EXPERIMENTAL
Intervention: Glypressin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pitressin
Number of subjects: 29
Study: 350388

Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum
Number of subjects: 76

Group type: COMPARATOR
Intervention: methanol extracted residue of bacillus Calmette‐Guérin (MER)
Number of subjects: 76

Group type: COMPARATOR
Intervention: No immunotherapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Combination chemotherapy (adriamycin, cyclophosphamide, cis‐dichlorodiammineplatinum(II), vincristine)
Number of subjects: 76
Study: 30931835

Group type: EXPERIMENTAL
Intervention: Intensive conventional phototherapy (Bilisphere 360)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intensive LED phototherapy (Bilitron bed 3600)
Number of subjects: 54
Study: 31005336

Group type: EXPERIMENTAL
Intervention: BI 425809 (10, 25, or 50 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 29091568

Group type: COMPARATOR
Intervention: ACE inhibitor
Number of subjects: 443

Group type: COMPARATOR
Intervention: Statin
Number of subjects: 443

Group type: COMPARATOR
Intervention: Combination of ACE inhibitor and statin
Number of subjects: 443
Study: 26521581

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment within first 72 hours after surgery, with needles retained for 30 minutes, given 6 times.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Postoperative routine care of hand surgery (Control group).
Number of subjects: 80
Study: 23806287

Group type: EXPERIMENTAL
Intervention: Ambulatory oxygen at 4 L/min intranasally
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ambulatory air at 4 L/min intranasally
Number of subjects: 20
Study: 21558575

Group type: EXPERIMENTAL
Intervention: Bovine colostrum supplementation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Skim-milk powder (control)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both groups (colostrum and skim-milk powder)
Number of subjects: 9
Study: 19423529

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/day for 6 months
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 143
Study: 16750790

Group type: EXPERIMENTAL
Intervention: Tourniquet
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study: 15087584

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 11763936

Group type: EXPERIMENTAL
Intervention: Prevident 5000 Plus (5000 ppm F)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Colgate Winterfresh Gel (1100 ppm F)
Number of subjects: 201
Study: 9368260

Group type: EXPERIMENTAL
Intervention: Asthma knowledge beliefs and management behavior; Caretakers demonstrated considerable asthma knowledge, averaging 84% correct responses on the Asthma Information Quiz.
Number of subjects: 1528

Group type: EXPERIMENTAL
Intervention: Child Behavior Checklist scores; children rated their responsibility for self-care significantly higher than adults.
Number of subjects: 1528

Group type: EXPERIMENTAL
Intervention: Brief Symptom Inventory scores; adults reported elevated levels of psychological distress.
Number of subjects: 1528

Group type: EXPERIMENTAL
Intervention: Life stress events; caretakers experienced undesirable life events.
Number of subjects: 1528
Study: 8111819

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg BID
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg QID
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 3797019

Group type: EXPERIMENTAL
Intervention: Quota setting alone
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Quota setting with monetary reinforcement
Number of subjects: 64

Group type: COMPARATOR
Intervention: Quota setting with placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Self-efficacy expectancies
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Self-efficacy expectancies and pain tolerance times at treatment
Number of subjects: 64
Study: 31452081

Group type: EXPERIMENTAL
Intervention: Extended interval dosing (EID) of natalizumab (MDI 6.2 weeks)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Standard interval dosing (SID) of natalizumab (MDI 4.3 weeks)
Number of subjects: 360
Study: 30514285

Group type: EXPERIMENTAL
Intervention: Personalised online lifestyle coaching application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard periconceptional advice including information from NHS websites
Number of subjects: 0
Study: 27449661

Group type: EXPERIMENTAL
Intervention: More intensive RRT (hemodialysis or sustained low‐efficiency dialysis six times per week or continuous venovenous hemodiafiltration at 35 ml/kg per hour)
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Less intensive RRT (hemodialysis or sustained low‐efficiency dialysis three times per week or continuous venovenous hemodiafiltration at 20 ml/kg per hour)
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: More intensive RRT
Number of subjects: 1124
Study: 24808487

Group type: EXPERIMENTAL
Intervention: Lutein supplement meal
Number of subjects: 39

Group type: COMPARATOR
Intervention: Tomato puree meal
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both meals
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Combination of 29 SNPs in 15 genes
Number of subjects: 39
Study: 22808712

Group type: EXPERIMENTAL
Intervention: Strength Training (ST) - 8-week program, three sessions/week, three sets of 10-12 repetition maximum, five different exercises
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (n=7)
Number of subjects: 17
Study: 20044684

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 103

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 103
Study: 18480921

Group type: EXPERIMENTAL
Intervention: Age-related educational programmes for long-term management of atopic dermatitis
Number of subjects: 823
Study: 15790459

Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m² IV infusion on day 1, Carboplatin AUC 6.0 IV on day 1, Etoposide 50 mg alternating with 100 mg orally on days 1-10, 6 courses at 21-day intervals
Number of subjects: 52